Allan N. Maroli
- Nephrology top 1%
- Surgery top 10%
- Rheumatology top 2%
- Molecular Biology
- Pharmacology top 5%
- Co-authors
- Royce W. WaltripMichael A. BeckerSteven L. BramerConstantin EfthymiopoulosHerbert S. B. BarafWilliam J. HuangJohn S. SundyPaul A. J. Janssen
- Topics
- Antibiotics Pharmacokinetics and Efficacy (8 papers)Pneumonia and Respiratory Infections (5 papers)Gout, Hyperuricemia, Uric Acid (5 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Allan N. Maroli
25 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Nephrology 592
- Surgery 414
- Rheumatology 361
- Molecular Biology 217
- Pharmacology 190
Countries citing papers authored by Allan N. Maroli
This map shows the geographic impact of Allan N. Maroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan N. Maroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan N. Maroli more than expected).
Fields of papers citing papers by Allan N. Maroli
This network shows the impact of papers produced by Allan N. Maroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan N. Maroli. The network helps show where Allan N. Maroli may publish in the future.
Co-authorship network of co-authors of Allan N. Maroli
This figure shows the co-authorship network connecting the top 25 collaborators of Allan N. Maroli. A scholar is included among the top collaborators of Allan N. Maroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan N. Maroli. Allan N. Maroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatmentbreakdown → | 380 |
| 2 | 135 | |
| 3 | 37 | |
| 4 | 129 | |
| 5 | 19 | |
| 6 | 11 | |
| 7 | 17 | |
| 8 | 18 | |
| 9 | 54 | |
| 10 | 52 | |
| 11 | 20 | |
| 12 | 32 | |
| 13 | 26 | |
| 14 | 9 | |
| 15 | 38 | |
| 16 | 2 | |
| 17 | 4 | |
| 18 | 79 | |
| 19 | 58 | |
| 20 | 10 |
About Allan N. Maroli
Allan N. Maroli is a scholar working on Nephrology, Pharmacology and Applied Microbiology and Biotechnology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). The work is most often cited by research in Nephrology (592 citations), Rheumatology (361 citations) and Molecular Medicine (75 citations). Allan N. Maroli has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Royce W. Waltrip, Michael A. Becker, Steven L. Bramer, Constantin Efthymiopoulos, Herbert S. B. Baraf, William J. Huang, John S. Sundy, Paul A. J. Janssen, C. J. E. Niemegeers and Edward L. Treadwell. Their work appears in journals such as JAMA, Cancer and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.